Will the SGLT2i Responders Please Stand Up?

HomeCirculation: Heart FailureAhead of PrintWill the SGLT2i Responders Please Stand Up? No AccessEditorialRequest AccessAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessEditorialRequest AccessWill the SGLT2i Responders Please Stand Up? Kane Banner and Daniel N. Silverman Kane BannerKane Banner College of Medicine, Medical University of South Carolina, Charleston. (K.B.) Search for more papers by this author and Daniel N. SilvermanDaniel N. Silverman Correspondence to: Daniel Silverman, MD, Medicine/Cardiology, Section of Advanced Heart Failure & Transplant Cardiology, 30 Courtenay Dr, BM326a, MSC592, Charleston, SC 29425. Email E-mail Address: [email protected] Division of Cardiology, Department of Medicine, Medical University of South Carolina, Charleston.(D.N.S.) Division of Cardiology, Ralph H. Johnson Department of Veterans Affairs Health Care System, Charleston, SC (D.N.S.). Search for more papers by this author Originally published23 Oct 2023https://doi.org/10.1161/CIRCHEARTFAILURE.123.011124Circulation: Heart Failure. 2023;0:e011124FootnotesThis manuscript was sent to Finn Gustafsson, Senior Guest Editor, for review by expert referees, editorial decision, and final dispositionFor Disclosures, see page xxx.The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.Correspondence to: Daniel Silverman, MD, Medicine/Cardiology, Section of Advanced Heart Failure & Transplant Cardiology, 30 Courtenay Dr, BM326a, MSC592, Charleston, SC 29425. Email silvermd@musc.edu Previous Back to top Next FiguresReferencesRelatedDetails Advertisement Article InformationMetrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/CIRCHEARTFAILURE.123.011124PMID: 37869883 Originally publishedOctober 23, 2023 Keywordsempagliflozinheart failureEditorialssodium/glucose cotransporter-2 inhibitordapagliflozinPDF download Advertisement SubjectsCardiomyopathyHeart Failure